Bionano Genomics Inc (BNGO)
0.4632
+0.02
(+4.94%)
USD |
NASDAQ |
Sep 27, 16:00
0.4726
+0.01
(+2.03%)
After-Hours: 20:00
Bionano Genomics SG&A Expense (Annual): 93.50M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 93.50M |
| December 31, 2022 | 88.60M |
| December 31, 2021 | 58.49M |
| December 31, 2020 | 31.07M |
| Date | Value |
|---|---|
| December 31, 2019 | 20.16M |
| December 31, 2018 | 14.22M |
| December 31, 2017 | 14.08M |
| December 31, 2016 | 12.95M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
20.16M
Minimum
2019
93.50M
Maximum
2023
58.36M
Average
58.49M
Median
2021
SG&A Expense (Annual) Benchmarks
| Revvity Inc | 1.023B |
| Bruker Corp | 730.10M |
| Azenta Inc | 316.28M |
| Harvard Bioscience Inc | 46.89M |
| Akoya Biosciences Inc | 82.38M |